Specifically, datasets of GEO were analyzed using PrognoScan showed that elevated Fam20C expression associated with worse prognosis in bladder, brain, colorectal, and lung cancers (Figure 2A,B,F–K). This evidence concerns the gene FAM20C and lung carcinoma.